Related Experiment Videos
Quantum leaps in treatment of high-risk breast cancer? Prove it!
1Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263.
European Journal of Cancer (Oxford, England : 1990)
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it?
Annals of oncology : official journal of the European Society for Medical Oncology·2014
3-[1-(4-Bromo-phen-yl)eth-oxy]-2,2,5-trimethyl-4-phenyl-3-aza-hexa-ne.
Acta crystallographica. Section E, Structure reports online·2014
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Diabetes, obesity & metabolism·2013
Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030).
British journal of cancer·2013
Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines.
British journal of cancer·2012
Characterization of Silver/Bovine Serum Albumin (Ag/BSA) nanoparticles structure: morphological, compositional, and interaction studies.
Journal of colloid and interface science·2012
70-gene signature MammaPrint for early-stage HR-positive, HER2-negative breast cancer: Outcome in the MINDACT trial for key clinical-pathological high-risk subgroups.
European journal of cancer (Oxford, England : 1990)·2026
Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.
European journal of cancer (Oxford, England : 1990)·2026
Genomic landscape of sweat gland carcinomas: Clinical applications and future directions.
European journal of cancer (Oxford, England : 1990)·2026
Organ-preserving surgery for solid pseudopapillary neoplasm of the pancreas: A multicentric study.
European journal of cancer (Oxford, England : 1990)·2026
Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.
European journal of cancer (Oxford, England : 1990)·2026
Triplet chemotherapy with Gemcitabine, Nab-paclitaxel, and S-1 achieves high response and conversion rates in advanced pancreatic cancer: A multicenter phase II study (GeNeS1S trial).
European journal of cancer (Oxford, England : 1990)·2026